Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Aetna (NYSE:AET) Had Its Price Target Raises by Researchers at RBC Capital Markets to $162.00

RBC Analyst Rating Change Aetna NYSE:AET

Aetna (NYSE:AET) Upside Target Change

In a report revealed to investors and clients by Rbc Capital Markets on Monday morning, Aetna (NYSE:AET) had its target price upped to $162.00. The firm presently has Outperform rating on the stock.

The target increase is well received by stock speculators, as NYSE:AET is at the moment trading 0.35% higher at $149.79 as of 8:28 AM New York time. Aetna shares have [From2] 0% in the last 200 days, while the S&P 500 has gained 6.00% in the same time period.

Out of 16 analysts covering Aetna, 15 rate it a Buy, 6 indicate a Hold while 1 suggest a Sell. The highest target is $163 and the lowest is $118 according to Thomson/First Call. The 12-month mean target is $138.56, which means downside potential of 7.50% over the current price.

Institutional Ownership

Michael & Susan Dell Foundation had the biggest stake with ownership of 140,786 shares as of q2 2015 for 16.39% of the US equity exposure. Glenview Capital Management Llc is another very bullish investment professional who is owning 5.18 million shares of Aetna or 4.28% of their US equity exposure. Moreover, Lyrical Asset Management Lp have 4.12% of their US equity exposure invested in the company for 1.82 million shares. The New York-based fund New Mountain Vantage Advisers L.L.C. revealed it had purchased so far a stake worth about 3.99% of the investment professional’s stock portfolio in Aetna. The California-based fund Endurant Capital Management Lp is also positive about the stock, possessing 588,693 shares or 3.58% of their US equity exposure.

Aetna (NYSE:AET) Profile

Aetna IncAetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Aetna (NYSE:AET) traded up 0.35% on 12 June, hitting $149.79. A total of 1.93 million shares of the company’s stock traded hands. This is down from average of 2.60 million shares. Aetna has a 52 week low of $104.59 and a 52 week high of $150.76. The company has a market cap of $49.85 billion and a P/E ratio of 46.48.

Get the latest Aetna (NYSE:AET) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Aetna (NYSE:AET) Had Its Price Target Raises by Researchers at RBC Capital Markets to $162.00 appeared first on Octafinance.



This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Aetna (NYSE:AET) Had Its Price Target Raises by Researchers at RBC Capital Markets to $162.00

×

Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription

×